Form 4: Guardant Health Director Sells 116 Shares

A director of Guardant Health, Tariq Musa, sold 116 shares of common stock at a price of $37.58 per share on January 17, 2025.

Summary

• Tariq Musa, a director at Guardant Health, sold 116 shares of the company's common stock.
• The transaction occurred on January 17, 2025.
• The sale price was $37.58 per share.
• Following the transaction, Mr. Musa directly owns 2,944 shares of Guardant Health stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to a stock sale by a director. It doesn't indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The sale of 116 shares by a director is a relatively small transaction and may not be indicative of any significant trend.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but the small size of the transaction is unlikely to cause significant concern.

Key Dates

Keywords

Guardant Health, Tariq Musa, stock sale, insider trading, Form 4, director